Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines

被引:43
作者
Marselli, L
Dotta, F
Piro, S
Santangelo, C
Masini, M
Lupi, R
Realacci, M
Del Guerra, S
Mosca, F
Boggi, U
Purrello, F
Navalesi, R
Marchetti, P
机构
[1] Univ Pisa, Dipartimento Endocrinol & Metab, Sez Metab, I-56100 Pisa, Italy
[2] Univ Roma La Sapienza, Dipartimento Sci Clin, Rome, Italy
[3] Univ Catania, Cattedra Endocrinol & Patol Costituz, Catania, Italy
[4] Univ Pisa, Dipartimento Oncol, Pisa, Italy
关键词
D O I
10.1210/jc.86.10.4974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies in rodents have suggested that Th2 and Th3 cytokines can be effective in reducing proinflammatory and Th1 cytokine-induced islet damage. Whether this is the case with human islets and might be due to a direct action of Th2 and Th3 cytokines is not known. In the present study, we evaluated whether Th2 (500 U/ml IL-4 plus 100 U/ml IL-10) or Th3 (5 ng/ml TGF-1 beta) cytokines may prevent the derangements induced on isolated human islets by prolonged (12 or 72 h) exposure to combined proinflammatory (50 U/ml IL-1 beta, 1000 U/ml TNF alpha) and Th1 (1000 U/ml interferon gamma) cytokines. Compared with control islets, cells preincubated for 12 or 72 h with proinflammatory and Th1 cytokines showed a significant decrease of glucose-stimulated insulin secretion and a significant increase of nitrites production. The addition of IL-4 plus IL-10 or TGF-1 beta in the medium prevented these cytostatic effects in the 12-h incubation experiments, but not after the 72-h exposure period. IL-1 beta, interferon gamma, and TNF alpha caused no major change in either islet cell survival or Bcl-2 and Bax mRNA expression after a 12-h incubation; however, a marked in. crease in the amount of dead cells, with a major decrease of Bcl-2 mRNA expression, was observed after 72 h. The presence of Th2, but not of Th3, cytokines significantly reduced beta -cell death, without any major effect on Bcl-2 and Bax mRNA expression. These results suggest that Th2 and (at lower extent) Th3 cytokines may have a partial, direct protective effect on isolated human islets exposed to the cytostatic and cytotoxic action of proinflammatory and Th1 cytokines.
引用
收藏
页码:4974 / 4978
页数:5
相关论文
共 34 条
[11]   Function of pancreatic islets isolated from a type 1 diabetic patient [J].
Marchetti, P ;
Dotta, F ;
Ling, ZD ;
Lupi, R ;
Del Guerra, S ;
Santangelo, C ;
Realacci, M ;
Marselli, L ;
Di Mario, U ;
Navalesi, R .
DIABETES CARE, 2000, 23 (05) :701-703
[12]  
Masiello P, 1984, Toxicol Pathol, V12, P274
[13]  
Minshall C, 1997, J IMMUNOL, V159, P1225
[14]  
Morabito F, 1998, HAEMATOLOGICA, V83, P1046
[15]   Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Mueller, R ;
Krahl, T ;
Sarvetnick, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1093-1099
[16]   ON THE PATHOGENESIS OF IDDM [J].
NERUP, J ;
MANDRUPPOULSEN, T ;
HELQVIST, S ;
ANDERSEN, HU ;
POCIOT, F ;
REIMERS, JI ;
CUARTERO, BG ;
KARLSEN, AE ;
BIERRE, U ;
LORENZEN, T .
DIABETOLOGIA, 1994, 37 :S82-S89
[18]   Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes - Effects on insulin release from human islets [J].
Pupilli, C ;
Giannini, S ;
Marchetti, P ;
Lupi, R ;
Antonelli, A ;
Malavasi, F ;
Takasawa, S ;
Okamoto, H ;
Ferrannini, E .
DIABETES, 1999, 48 (12) :2309-2315
[19]   HUMAN PANCREATIC-ISLET BETA-CELL DESTRUCTION BY CYTOKINES IS INDEPENDENT OF NITRIC-OXIDE PRODUCTION [J].
RABINOVITCH, A ;
SUAREZPINZON, WL ;
STRYNADKA, K ;
SCHULZ, R ;
LAKEY, JRT ;
WARNOCK, GL ;
RAJOTTE, RV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) :1058-1062
[20]   COMBINED THERAPY WITH INTERLEUKIN-4 AND INTERLEUKIN-10 INHIBITS AUTOIMMUNE DIABETES RECURRENCE IN SYNGENEIC ISLET-TRANSPLANTED NONOBESE DIABETIC MICE - ANALYSIS OF CYTOKINE MESSENGER-RNA EXPRESSION IN THE GRAFT [J].
RABINOVITCH, A ;
SUAREZPINZON, WL ;
SORENSEN, O ;
BLEACKLEY, RC ;
POWER, RF ;
RAJOTTE, RV .
TRANSPLANTATION, 1995, 60 (04) :368-374